<!doctype html><html lang=en><meta charset=utf-8><meta name=generator content="Hugo 0.78.1"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=color-scheme content="light dark"><meta name=supported-color-schemes content="light dark"><title>Zhu 2016&nbsp;&ndash;&nbsp;Papers</title><link rel=stylesheet href=/stevengogogo/PaperNotes/css/core.min.0e6154f1fe5441faaa4f418ca1a607b9f3edbad43b1ab8782737ee279ca2c5a48c8dbe23af3340af50c91a2558bc2b55.css integrity=sha384-DmFU8f5UQfqqT0GMoaYHufPtutQ7Grh4JzfuJ5yixaSMjb4jrzNAr1DJGiVYvCtV><meta name=twitter:card content="summary"><meta name=twitter:title content="Zhu 2016"><body><section id=header><div class="header wrap"><span class="header left-side"><a class="site home" href=/stevengogogo/PaperNotes/><span class="site name">Papers</span></a></span>
<span class="header right-side"><div class="nav wrap"><nav class=nav><a class="nav item" href=/stevengogogo/PaperNotes/categories/>Categories</a><a class="nav item" href=/stevengogogo/PaperNotes/tags/>Tags</a></nav></div></span></div><div class="site slogan"><span class=title>Collection of papers I read</span></div></section><section id=content><div class=article-container><section class="article header"><h1 class="article title">Zhu 2016</h1><p class="article date">2020-10-23</p></section><article class="article markdown-body"><p><a href=https://sciwheel.com/work/#/items/5848395 target=_blank>Sciwheel</a></p><p><a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921833/ target=_blank>Article</a><sup id=fnref:1><a href=#fn:1 class=footnote-ref role=doc-noteref>1</a></sup></p><h2 id=overview>OVERVIEW</h2><ul><li>DOX&rsquo;s mechanisms of action underlying cancer cell killing and induction of cardiotoxicity and heart failure, a major limiting factor of the drug’s clinical use, remain to be further elucidated</li><li>redox cycling in mitochondria, topoisomerase inhibition, and oxidative stress</li></ul><h2 id=oxidative-stress>OXIDATIVE STRESS</h2><ul><li>tightly regulated production of reactive oxygen species (ROS) is a fundamental mechanism of innate immunity and physiological homeostasis</li></ul><h3 id=doxorubicin-mediated-oxidative-stress>Doxorubicin-Mediated Oxidative Stress</h3><ul><li>decreased expression of cellular antioxidant defenses</li><li>activation of ROS-generating enzymes/proteins, including NOX2 and Rac1</li><li>disruption of the mitochondrial electron transport chain (ETC) by doxorubicin either directly (cardiolipin insertion) or indirectly (mtDNA damage)</li></ul><h3 id=nrf2-signaling>Nrf2 Signaling</h3><ul><li>Short term exposure to doxorubicin may cause activation of Nrf2 (nuclear factor E2-related factor 2), leading to transient increases in antioxidant gene expression</li></ul><h2 id=redox-cycling>REDOX CYCLING</h2><p><img src=https://user-images.githubusercontent.com/40054455/96907373-bc9a1d80-14cd-11eb-9354-69b98f2e8463.png alt=image>
<img src=https://user-images.githubusercontent.com/40054455/96907388-c02da480-14cd-11eb-8cbb-3558dd380921.png alt=image></p><ul><li>there is no direct evidence for doxorubicin to undergo redox cycling to generate ROS at pharmacologically relevant concentrations (0.1-1.0 μM) in target cells and tissues</li></ul><h2 id=topoisomerase-inhibition>TOPOISOMERASE INHIBITION</h2><p><img src=https://user-images.githubusercontent.com/40054455/86727443-07e30a00-c05e-11ea-82cb-07a45603ca06.png alt=tbl1></p><ul><li>Doxorubicin-induced anticancer activity from inhibition of TOP => dsDNA breaks</li><li><strong>topoisomerase IIβ</strong> (TOP2B) in haert mitochondria are also affected. topoisomerase IIb serves as a mediator, rather than an ultimate target, of doxorubicin-induced cardiotoxicity
<img src=https://user-images.githubusercontent.com/40054455/96907429-c9b70c80-14cd-11eb-8b5c-8db641bfa69d.png alt=image>
<img src=https://user-images.githubusercontent.com/40054455/96907422-c754b280-14cd-11eb-8f4e-4e8a344f4530.png alt=image></li><li>inhibit doxorubicin’s binding to topoisomerase IIb would be effective (e.g. dexrazoxane)</li></ul><h2 id=molecular-target-driven-strategies-for-improving-doxorubicins-therapeutic-index>MOLECULAR TARGET-DRIVEN STRATEGIES FOR IMPROVING DOXORUBICIN’S THERAPEUTIC INDEX</h2><ul><li>so far <strong>no antioxidants</strong> have been shown to protect against doxorubicin’s cardiotoxicity or augment its anticancer activity in human cancer patients. (Not mito-targeted?)</li><li>dexrazoxane: iron chelator, inhibits DOX binding to topIIβ</li><li>novel agents that enhance doxorubicin-induced tumoricidal activity?</li></ul><h2 id=reference>Reference</h2><section class=footnotes role=doc-endnotes><hr><ol><li id=fn:1 role=doc-endnote><p>Zhu H, Sarkar S, Scott L, et al. Doxorubicin redox biology: redox cycling, topoisomerase inhibition, and oxidative stress. React Oxyg Species (Apex) 2016;1(3):189-198. <a href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921833 target=_blank>PMC5921833</a> <a href=#fnref:1 class=footnote-backref role=doc-backlink>&#8617;&#xfe0e;</a></p></li></ol></section></article><section class="article author"><p class=name>Shao-Ting Chiu</p><div class=details><a class=item href=https://github.com/stevengogogo target=_blank><span class="iconfont icon-github"></span>&nbsp;stevengogogo</a></div></section></div><div class="article bottom"><section class="article navigation"><p><a class=link href=/stevengogogo/PaperNotes/posts/yang-2018/><span class="iconfont icon-article"></span>Yang 2018</a></p><p><a class=link href=/stevengogogo/PaperNotes/posts/zhou-2014/><span class="iconfont icon-article"></span>Zhou 2014</a></p></section></div></section><section id=footer><div class=footer-wrap><p class=copyright>Papers</p><p class=powerby><span>Powered&nbsp;by&nbsp;</span><a href=https://gohugo.io target=_blank>Hugo</a><span>&nbsp;&&nbsp;</span><a href=https://themes.gohugo.io/hugo-notepadium/ target=_blank>Notepadium</a></p></div></section><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css integrity=sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js integrity=sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz crossorigin=anonymous></script><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body);></script></body></html>